Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

2027 NHMRC-European Partnership on One Health Antimicrobial Resistance

Open
GO8740Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Estimated contract value

Up to A$500,000

NAICS

N/A

Place of Performance

AUS

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Due in 237 days

Get what you need to respond

No documents were posted with this contract.

  • Buyer contactEmail
  • Original solicitationLink to the source posting
Get the buyer contact

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

Posted

Contract opportunity posted

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyAustralian Government → National Health and Medical Research Council (NHMRC)
Contacts1 person available
OfficeN/A

Full Description

Show more
The 2027 NHMRC-European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) scheme supports Australian participation and collaboration in transnational research projects through the EUP OHAMR. EUP OHAMR facilitates collaboration and strengthens research impact to address antimicrobial resistance challenges across sectors and One Health domains. Proposals involving Australia-based researchers who have been invited by EUP OHAMR to submit a full proposal may be eligible for NHMRC support. NHMRC will be supporting the below topics: • Topic 1 - Model AMR transmission dynamics to predict the risk of AMR emergence and spread to support decision making of public authorities • Topic 2 - Understand and characterise the role of host commensal micro-organisms (including fungi) in AMR dynamics and develop solutions aiming at selective decolonising of resistant organisms in the host (human and animals) to prevent transmission • Topic 3 - Develop or improve tools and methods to reduce resistant bacteria, fungi, and resistance genes in environmental hotspots, and investigate the impact of these tools and methods on AMR Transmission.

More opportunities from Australian Government → National Health and Medical Research Council (NHMRC)

Same awarding agency

NAICS: 541715
Grant
MRFF – EPCDRI – 2026 Improving Health Interventions and Services through Implementation Research Grant Opportunity
Solicitation # GO8671
The MRFF EPCDRI 2026 Improving Health Interventions and Services through Implementation Research Grant Opportunity, administered by the NHMRC on behalf of the Australian Government, provides financial assistance for medical research and innovation. The program is divided into two distinct streams: Stream 1 focuses on co-designed proof of concept or pilot studies to establish feasibility and impact, while Stream 2 supports multidisciplinary implementation research aimed at improving the adoption and scaling of evidence-based health interventions. Applicants must partner with health service providers and consumers, focus on priority populations, and demonstrate how their novel research will translate into tangible health benefits for Australians. This federal opportunity offers a total program funding pool of 20 million dollars, with an award ceiling of 5 million dollars. Interested eligible organizations must submit their applications to only one of the two available streams by the deadline of March 3, 2027. The primary goal of the initiative is to enhance the quality and effectiveness of health and wellbeing services across Australia by building a robust evidence base for the implementation of health interventions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS